3,405
Views
67
CrossRef citations to date
0
Altmetric
Research Papers

Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9

, , , , , , , , , , , , , , , , , , , & show all
Pages 990-999 | Received 16 Jun 2017, Accepted 15 Oct 2017, Published online: 27 Nov 2017

References

  • Kanis MJ, Kolev V, Getrajdman J, Zakashansky K, Cohen C, Rahaman J. Carcinosarcoma of the ovary: a single institution experience and review of the literature. Eur J Gynaecol Oncol. 2016;37(1):75–9.
  • Siegel RL, Miller KD, and Jemal A, Cancer statistics, 2016. Ca A Cancer Journal for Clinicians. 2016;66(1):10–29. doi:10.3322/caac.21332.
  • Schummer M, Drescher C, Forrest R, Gough S, Thorpe J, Hellström I, Hellström KE, Urban N. Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125. Gynecologic Oncology. 2012;125(1):65–9. doi:10.1016/j.ygyno.2011.11.050.
  • Sung PL, Chang YH, Chao KC, Chuang CM; Task Force on Systematic Review and Meta-analysis of Ovarian Cancer. Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review. Gynecol Oncol. 2014;133(2):147–54. doi:10.1016/j.ygyno.2014.02.016.
  • Cetin I, Cozzi V, and Antonazzo P, Infertility as a cancer risk factor − a review. Placenta. 2008;29 Suppl B:169–77. doi:10.1016/j.placenta.2008.08.007.
  • Hung LJ, Chan TF, Wu CH, Chiu HF, Yang CY. Traffic air pollution and risk of death from ovarian cancer in Taiwan: fine particulate matter (PM2.5) as a proxy marker. J Toxicol Environ Health A. 2012;75(3):174–82. doi:10.1080/15287394.2012.641200.
  • Hannibal CG, Vang R, Junge J, Frederiksen K, Kurman RJ, Kjaer SK. A nationwide study of ovarian serous borderline tumors in Denmark 1978−2002. Risk of recurrence, and development of ovarian serous carcinoma. Gynecol Oncol. 2017;114(1):147–80. doi:10.1016/j.ygyno.2017.11.007.
  • Weidle UH, Birzele F, Kollmorgen G, Rueger R. Mechanisms and Targets Involved in Dissemination of Ovarian Cancer. Cancer Genomics Proteomics. 2016;13(6):407–423. doi:10.21873/cgp.20004.
  • Monk BJ, Herzog TJ, and Tewari KS, Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients. Curr Pharm Des. 2016;22(30):4717–4728. doi:10.2174/1381612822666160505114326.
  • Zhang DM, Xu HG, Wang L, Li YJ, Sun PH, Wu XM, Wang GJ, Chen WM, Ye WC. Betulinic Acid and its Derivatives as Potential Antitumor Agents. Medicinal research reviews. 2015;35(6):1127–55. doi:10.1002/med.21353. Epub 2015 Jun 2.
  • Hao J, Zhu C, Cao R, Yang X, Ding X, Man Y, Wu X. [Purple-bluish tongue is associated with platelet counts, and the recurrence of epithelial ovarian cancer]. J Tradit Chin Med. 2016;36(3):321–5. doi:10.1016/S0254-6272(16)30044-9.
  • Ai B, Bie Z, Zhang S, Li A. Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment. Am J Cancer Res. 2016;6(8):1624–35.
  • Verma RP and Hansch C, Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry. 2007;15(6):2223–68. doi:10.1016/j.bmc.2007.01.011.
  • Coussens LM and Werb Z, Matrix metal loproteinases and the development of cancer. Chemistry & Biology, 1996;3(11):895–904. doi:10.1016/S1074-5521(96)90178-7.
  • Cheung LWT, Leung PCK, and Wong AST, Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase–Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9. Cancer Res. 2006;66(22):10902–10. doi:10.1158/0008-5472.CAN-06-2217.
  • Lu YM, Rong ML, Shang C, Wang N, Li X, Zhao YY, Zhang SL. Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV-3 human ovarian carcinoma cells. Oncology Reports. 2012;29(3):1133–9. doi:10.3892/or.2012.2214.
  • Yu Y, Li H, Xue B, Jiang X, Huang K, Ge J, Zhang H, Chen B. SDF-1/CXCR7 axis enhances ovarian cancer cell invasion by MMP-9 expression through p38 MAPK pathway. Dna & Cell Biology. 2014;33(8):543–9. doi:10.1089/dna.2013.2289.
  • Spilmont M, Léotoing L, Davicco MJ, Lebecque P, Mercier S, Miot-Noirault E, Pilet P, Rios L, Wittrant Y, Coxam V. Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis. Eur J Nutr. 2014;53(5):1155–64. doi:10.1007/s00394-013-0615-6.
  • Costantini S, Rusolo F, De Vito V MS, Picariello G, Capone F, Guerriero E, Castello G, Volpe MG. Potential anti-inflammatory effects of the hydrophilic fraction of pomegranate (Punica granatum L.) seed oil on breast cancer cell lines. Molecules. 2014;19(6):8644–60. doi:10.3390/molecules19068644.
  • Faria A, Calhau C, The bioactivity of pomegranate: impact on health and disease. Critical Reviews in Food Science & Nutrition. 2011;51(51):626–34. doi:10.1080/10408391003748100.
  • Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. Journal of Clinical Oncology. 2009;27(16):2712–25. doi:10.1200/JCO.2008.20.6235.
  • Syed DN, Afaq F, Mukhtar H, Pomegranate derived products for cancer chemoprevention. Seminars in Cancer Biology. 2007;17(5):377–85. doi:10.1016/j.semcancer.2007.05.004.
  • Jurenka JS, Therapeutic applications of pomegranate (Punica granatum L.): a review. Alternative Medicine Review A Journal of Clinical Therapeutic. 2008;13(2):128–44.
  • Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. Journal of Nutritional Biochemistry. 2005;16(6):360–7. doi:10.1016/j.jnutbio.2005.01.006.
  • Turrini E, Ferruzzi L, and Fimognari C, Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy. Oxidative Medicine & Cellular Longevity. 2015;2015:1–19. doi:10.1155/2015/938475.
  • Lópezlázaro M, Distribution and biological activities of the flavonoid luteolin. Mini Reviews in Medicinal Chemistry. 2009;9(1):31–59. doi:10.2174/138955709787001712.
  • Amrutha K, Nanjan P, Shaji SK, Sunilkumar D, Subhalakshmi K, Rajakrishna L, Banerji A. Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells—A SAR study. Bioorganic & Medicinal Chemistry Letters. 2014;24(19):4735–4742. doi:10.1016/j.bmcl.2014.07.093.
  • Pandurangan AK, Dharmalingam P, Sadagopan SK, Ganapasam S. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Human & Experimental Toxicology. 2014;33(11):1176–85. doi:10.1177/0960327114522502.
  • Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. Journal of Nutrition. 2006;136(10):2481–5.
  • Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural & Food Chemistry. 2000;48(10):4581–9. doi:10.1021/jf000404a.
  • Mehta R and Lansky EP, Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. European Journal of Cancer Prevention. 2004;13(4):345–348. doi:10.1097/01.cej.0000136571.70998.5a.
  • Tsuda H, Uehara N, Iwahori Y, Asamoto M, Iigo M, Nagao M, Matsumoto K, Ito M, Hirono I. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn J Cancer Res. 1994;85(12):1214–9. doi:10.1111/j.1349-7006.1994.tb02932.x.
  • Tharappel JC, Lehmler HJ, Srinivasan C, Robertson LW, Spear BT, Glauert HP. Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3′,4,4′-tetrachlorobiphenyl (PCB-77). Food Chem Toxicol. 2008;46(11):3467–74. doi:10.1016/j.fct.2008.08.023.
  • Shirode AB, Kovvuru P, Chittur SV, Henning SM, Heber D, Reliene R. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol Carcinog. 2014;53(6):458–70. doi:10.1002/mc.21995.
  • Wang L and Martins-Green. M, Pomegranate and its components as alternative treatment for prostate cancer. Int J Mol Sci. 2014;15(9):14949–66. doi:10.3390/ijms150914949.
  • Jaganathan SK, Vellayappan MV, Narasimhan G, Supriyanto E. Role of pomegranate and citrus fruit juices in colon cancer prevention. World J Gastroenterol. 2014;20(16):4618–25. doi:10.3748/wjg.v20.i16.4618.
  • Mieszalo K, Lawicki S, and Szmitkowski M, [The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies]. Pol Merkur Lekarski. 2016;40(237):193–7.
  • Turrini E, Ferruzzi L, and Fimognari C, Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy. Oxidative Medicine & Cellular Longevity. 2014;2015:1–19. doi:10.1155/2015/938475.
  • Nair V, Dai Z, Khan M, Ciolino HP. Pomegranate extract induces cell cycle arrest and alters cellular phenotype of human pancreatic cancer cells. Anticancer Research. 2011;31(9):2699–704.
  • Huang ST, Wang CY, Yang RC, Wu HT, Yang SH, Cheng YC, Pang JH. Ellagic Acid, the Active Compound of Phyllanthus urinaria, Exerts In Vivo Anti-Angiogenic Effect and Inhibits MMP-2 Activity. Evidence-based complementary and alternative medicine: eCAM. 2011;2011(5):296–297.
  • Dammer EB, Göttle M, Duong DM, Hanfelt J, Seyfried NT, Jinnah HA. Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease. Mol Genet Metab. 2015;114(4):570–9. doi:10.1016/j.ymgme.2015.02.007.
  • Zhu TX, Lan B, Meng LY, Yang YL, Li RX, Li EM, Zheng SY, Xu LY. ECM-related gene expression profile in vascular smooth muscle cells from human saphenous vein and internal thoracic artery. J Cardiothorac Surg. 2013;8:155. doi:10.1186/1749-8090-8-155.
  • Chung YC, Lu LC, Tsai MH, Chen YJ, Chen YY, Yao SP, Hsu CP. The inhibitory effect of ellagic Acid on cell growth of ovarian carcinoma cells. Evidence-based Complementary and Alternative Medicine. 2013;2013(2):386–386.
  • Amakura Y, Okada M, Tsuji S, Tonogai Y. High-performance liquid chromatographic determination with photodiode array detection of ellagic acid in fresh and processed fruits. Journal of Chromatography A. 2000;896(1–2):87–93. doi:10.1016/S0021-9673(00)00414-3.
  • Miean KH and Mohamed S, Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. Journal of Agricultural & Food Chemistry. 2001;49(6):3106–12. doi:10.1021/jf000892m.
  • Langers AM, Verspaget HW, Hawinkels LJ, Kubben FJ, van Duijn W, van der Reijden JJ, Hardwick JC, Hommes DW, Sier CF. MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients. Br J Cancer. 2012;106(9):1495–8. doi:10.1038/bjc.2012.80.